🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
05/09/2007 0,3626 USD
06/06/2007 0,3626 USD
07/03/2007 0,3626 USD
06/12/2006 0,3626 USD
30/08/2006 0,3626 USD
31/05/2006 0,3626 USD
08/03/2006 0,3626 USD
30/11/2005 0,3626 USD
31/08/2005 0,3626 USD
01/06/2005 0,3626 USD
02/03/2005 0,3626 USD
01/12/2004 0,3626 USD
01/09/2004 0,3626 USD
02/06/2004 0,3531 USD
03/03/2004 0,3531 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/02/1994 15,80 15,86 15,63 15,68 -0,75% 1,51% 6.727.950
17/02/1994 16,04 16,04 15,68 15,80 +0,00% 2,23% 6.549.371
16/02/1994 16,04 16,10 15,74 15,80 -1,85% 2,23% 7.395.317
15/02/1994 16,10 16,22 15,98 16,10 +0,00% 1,48% 7.153.648
14/02/1994 16,64 16,64 16,10 16,10 -3,23% 3,23% 7.449.813
11/02/1994 16,52 16,88 16,46 16,64 +0,00% 2,53% 4.485.650
10/02/1994 16,64 16,94 16,58 16,64 +0,00% 2,15% 7.018.875
09/02/1994 16,52 16,64 16,40 16,64 +1,09% 1,44% 3.995.605
08/02/1994 16,76 16,76 16,40 16,46 -1,78% 2,14% 6.076.304
07/02/1994 16,64 16,88 16,64 16,76 +0,00% 1,43% 7.206.886
04/02/1994 17,47 17,47 16,70 16,76 -3,77% 4,44% 5.906.738
03/02/1994 17,29 17,53 16,88 17,41 +0,34% 3,79% 6.121.158
02/02/1994 17,29 17,41 17,24 17,35 +0,35% 1,03% 3.964.794
01/02/1994 17,35 17,41 17,24 17,29 -0,69% 1,03% 4.555.027
31/01/1994 17,29 17,41 17,18 17,41 +1,39% 1,38% 5.644.947
28/01/1994 17,18 17,41 17,00 17,18 +0,70% 2,43% 5.556.077
27/01/1994 17,12 17,18 16,94 17,06 -0,35% 1,39% 3.822.685
26/01/1994 16,88 17,18 16,88 17,12 +0,35% 1,77% 5.677.226
25/01/1994 16,64 17,12 16,58 17,06 +2,88% 3,23% 8.600.098
24/01/1994 16,70 16,82 16,46 16,58 -1,07% 2,14% 6.323.842
21/01/1994 16,94 17,00 16,34 16,76 -1,75% 3,87% 7.168.949
20/01/1994 17,00 17,12 16,88 17,06 -0,35% 1,40% 6.127.237
19/01/1994 17,41 17,47 16,94 17,12 -2,05% 3,08% 9.641.181
18/01/1994 17,47 17,71 17,41 17,47 +0,34% 1,71% 5.874.040
17/01/1994 17,35 17,53 17,29 17,41 +0,00% 1,37% 3.936.917
14/01/1994 17,47 17,65 17,29 17,41 -0,34% 2,05% 4.759.806
13/01/1994 17,41 17,53 17,35 17,47 +0,00% 1,03% 3.682.462
12/01/1994 17,71 17,71 17,41 17,47 -1,35% 1,68% 5.160.352
11/01/1994 17,89 17,89 17,53 17,71 -1,00% 2,00% 5.256.978
10/01/1994 17,77 17,95 17,59 17,89 +1,01% 2,01% 6.402.861